Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 82 entries
Sorted by: Best Match Show Resources per page
Correction: The Influence of Hormonal Factors on the Risk of Developing Cervical Cancer and Pre-Cancer: Results from the EPIC Cohort.

PloS one

Roura E, Travier N, Waterboer T, de Sanjosé S, Bosch FX, Pawlita M, Pala V, Weiderpass E, Margall N, Dillner J, Gram IT, Tjønneland A, Munk C, Palli D, Khaw KT, Overvad K, Clavel-Chapelon F, Mesrine S, Fournier A, Fortner RT, Ose J, Steffen A, Trichopoulou A, Lagiou P, Orfanos P, Masala G, Tumino R, Sacerdote C, Polidoro S, Mattiello A, Lund E, Peeters PH, Bueno-de-Mesquita HB, Ramón Quirós J, Sánchez MJ, Navarro C, Barricarte A, Larrañaga N, Ekström J, Lindquist D, Idahl A, Travis RC, Merritt MA, Gunter MJ, Rinaldi S, Tommasino M, Franceschi S, Riboli E, Castellsagué X.
PMID: 26954296
PLoS One. 2016 Mar 08;11(3):e0151427. doi: 10.1371/journal.pone.0151427. eCollection 2016.

No abstract available.

Cite
Roura E, Travier N, Waterboer T, et al. Correction: The Influence of Hormonal Factors on the Risk of Developing Cervical Cancer and Pre-Cancer: Results from the EPIC Cohort. PLoS One. 2016;11(3):e0151427doi: 10.1371/journal.pone.0151427.
Roura, E., Travier, N., Waterboer, T., de Sanjosé, S., Bosch, F. X., Pawlita, M., Pala, V., Weiderpass, E., Margall, N., Dillner, J., Gram, I. T., Tjønneland, A., Munk, C., Palli, D., Khaw, K. T., Overvad, K., Clavel-Chapelon, F., Mesrine, S., Fournier, A., Fortner, R. T., Ose, J., Steffen, A., Trichopoulou, A., Lagiou, P., Orfanos, P., Masala, G., Tumino, R., Sacerdote, C., Polidoro, S., Mattiello, A., Lund, E., Peeters, P. H., Bueno-de-Mesquita, H. B., Ramón Quirós, J., Sánchez, M. J., Navarro, C., Barricarte, A., Larrañaga, N., Ekström, J., Lindquist, D., Idahl, A., Travis, R. C., Merritt, M. A., Gunter, M. J., Rinaldi, S., Tommasino, M., Franceschi, S., Riboli, E., & Castellsagué, X. (2016). Correction: The Influence of Hormonal Factors on the Risk of Developing Cervical Cancer and Pre-Cancer: Results from the EPIC Cohort. PloS one, 11(3), e0151427. https://doi.org/10.1371/journal.pone.0151427
Roura, Esther, et al. "Correction: The Influence of Hormonal Factors on the Risk of Developing Cervical Cancer and Pre-Cancer: Results from the EPIC Cohort." PloS one vol. 11,3 (2016): e0151427. doi: https://doi.org/10.1371/journal.pone.0151427
Roura E, Travier N, Waterboer T, de Sanjosé S, Bosch FX, Pawlita M, Pala V, Weiderpass E, Margall N, Dillner J, Gram IT, Tjønneland A, Munk C, Palli D, Khaw KT, Overvad K, Clavel-Chapelon F, Mesrine S, Fournier A, Fortner RT, Ose J, Steffen A, Trichopoulou A, Lagiou P, Orfanos P, Masala G, Tumino R, Sacerdote C, Polidoro S, Mattiello A, Lund E, Peeters PH, Bueno-de-Mesquita HB, Ramón Quirós J, Sánchez MJ, Navarro C, Barricarte A, Larrañaga N, Ekström J, Lindquist D, Idahl A, Travis RC, Merritt MA, Gunter MJ, Rinaldi S, Tommasino M, Franceschi S, Riboli E, Castellsagué X. Correction: The Influence of Hormonal Factors on the Risk of Developing Cervical Cancer and Pre-Cancer: Results from the EPIC Cohort. PLoS One. 2016 Mar 08;11(3):e0151427. doi: 10.1371/journal.pone.0151427. eCollection 2016. PMID: 26954296; PMCID: PMC4783099.
Copy Download .nbib Format: NLM
Post-operative Aspergillus mediastinitis in a man who was immunocompetent: a case report.

Journal of medical case reports

Dimopoulos G, Tsangaris I, Poulakou G, Panayiotides J, Tsaknis G, Orfanos S, Armaganides A.
PMID: 20863378
J Med Case Rep. 2010 Sep 23;4:312. doi: 10.1186/1752-1947-4-312.

INTRODUCTION: Aspergillus spp. infections mainly affect patients who are immunocompromised, and are extremely rare in immunocompetent individuals.CASE PRESENTATION: Aspergillus post-operative mediastinitis is considered to be a devastating infection, usually affecting patients undergoing cardiothoracic surgery with specific predisposing factors. We...

Cite
Dimopoulos G, Tsangaris I, Poulakou G, et al. Post-operative Aspergillus mediastinitis in a man who was immunocompetent: a case report. J Med Case Rep. 2010;4:312doi: 10.1186/1752-1947-4-312.
Dimopoulos, G., Tsangaris, I., Poulakou, G., Panayiotides, J., Tsaknis, G., Orfanos, S., & Armaganides, A. (2010). Post-operative Aspergillus mediastinitis in a man who was immunocompetent: a case report. Journal of medical case reports, 4312. https://doi.org/10.1186/1752-1947-4-312
Dimopoulos, George, et al. "Post-operative Aspergillus mediastinitis in a man who was immunocompetent: a case report." Journal of medical case reports vol. 4 (2010): 312. doi: https://doi.org/10.1186/1752-1947-4-312
Dimopoulos G, Tsangaris I, Poulakou G, Panayiotides J, Tsaknis G, Orfanos S, Armaganides A. Post-operative Aspergillus mediastinitis in a man who was immunocompetent: a case report. J Med Case Rep. 2010 Sep 23;4:312. doi: 10.1186/1752-1947-4-312. PMID: 20863378; PMCID: PMC2955057.
Copy Download .nbib Format: NLM
Impact of 3 Common ABCA1 Gene Polymorphisms on Optimal vs Non-Optimal Lipid Profile in Greek Young Nurses.

The open cardiovascular medicine journal

Marvaki A, Kolovou V, Katsiki N, Boutsikou M, Kotanidou A, Orfanos S, Filippatos G, Marvaki K, Koumoulidis A, Mavrogeni S, Kolovou G.
PMID: 25279016
Open Cardiovasc Med J. 2014 Sep 25;8:83-7. doi: 10.2174/1874192401408010083. eCollection 2014.

OBJECTIVE: This study is in line with two previous ones from our group. They evaluated the influence of ATP-binding cassette transporter A1 (ABCA1) gene polymorphisms [such as rs2230806 (R219K), rs2230808 (R1587K) and rs4149313 (I883M)] on the human lipid profile...

Cite
Marvaki A, Kolovou V, Katsiki N, et al. Impact of 3 Common ABCA1 Gene Polymorphisms on Optimal vs Non-Optimal Lipid Profile in Greek Young Nurses. Open Cardiovasc Med J. 2014;8:83-7doi: 10.2174/1874192401408010083.
Marvaki, A., Kolovou, V., Katsiki, N., Boutsikou, M., Kotanidou, A., Orfanos, S., Filippatos, G., Marvaki, K., Koumoulidis, A., Mavrogeni, S., & Kolovou, G. (2014). Impact of 3 Common ABCA1 Gene Polymorphisms on Optimal vs Non-Optimal Lipid Profile in Greek Young Nurses. The open cardiovascular medicine journal, 883-7. https://doi.org/10.2174/1874192401408010083
Marvaki, Apostolia, et al. "Impact of 3 Common ABCA1 Gene Polymorphisms on Optimal vs Non-Optimal Lipid Profile in Greek Young Nurses." The open cardiovascular medicine journal vol. 8 (2014): 83-7. doi: https://doi.org/10.2174/1874192401408010083
Marvaki A, Kolovou V, Katsiki N, Boutsikou M, Kotanidou A, Orfanos S, Filippatos G, Marvaki K, Koumoulidis A, Mavrogeni S, Kolovou G. Impact of 3 Common ABCA1 Gene Polymorphisms on Optimal vs Non-Optimal Lipid Profile in Greek Young Nurses. Open Cardiovasc Med J. 2014 Sep 25;8:83-7. doi: 10.2174/1874192401408010083. eCollection 2014. PMID: 25279016; PMCID: PMC4181169.
Copy Download .nbib Format: NLM
Yeast Biofilm as a Bridge Between Medical and Environmental Microbiology Across Different Detection Techniques.

Infectious diseases and therapy

Roscini L, Vassiliou A, Corte L, Casagrande Pierantoni D, Robert V, Tascini C, Mattana S, Alunni Cardinali M, Orfanos SE, Fioretto D, Cardinali G.
PMID: 29549654
Infect Dis Ther. 2018 Mar;7:27-34. doi: 10.1007/s40121-018-0191-4. Epub 2018 Mar 16.

Medical and environmental microbiology have two distinct, although very short, histories stemming, the first from the pioneering works of Sommelweiss, Pasteur, Lister and Koch, the second mainly from the studies of Bejerink and Winogradsky. These two branches of microbiology...

Cite
Roscini L, Vassiliou A, Corte L, et al. Yeast Biofilm as a Bridge Between Medical and Environmental Microbiology Across Different Detection Techniques. Infect Dis Ther. 2018;7:27-34doi: 10.1007/s40121-018-0191-4.
Roscini, L., Vassiliou, A., Corte, L., Casagrande Pierantoni, D., Robert, V., Tascini, C., Mattana, S., Alunni Cardinali, M., Orfanos, S. E., Fioretto, D., & Cardinali, G. (2018). Yeast Biofilm as a Bridge Between Medical and Environmental Microbiology Across Different Detection Techniques. Infectious diseases and therapy, 727-34. https://doi.org/10.1007/s40121-018-0191-4
Roscini, Luca, et al. "Yeast Biofilm as a Bridge Between Medical and Environmental Microbiology Across Different Detection Techniques." Infectious diseases and therapy vol. 7 (2018): 27-34. doi: https://doi.org/10.1007/s40121-018-0191-4
Roscini L, Vassiliou A, Corte L, Casagrande Pierantoni D, Robert V, Tascini C, Mattana S, Alunni Cardinali M, Orfanos SE, Fioretto D, Cardinali G. Yeast Biofilm as a Bridge Between Medical and Environmental Microbiology Across Different Detection Techniques. Infect Dis Ther. 2018 Mar;7:27-34. doi: 10.1007/s40121-018-0191-4. Epub 2018 Mar 16. PMID: 29549654; PMCID: PMC5856731.
Copy Download .nbib Format: NLM
Α 10-gigawatt attosecond source for non-linear XUV optics and XUV-pump-XUV-probe studies.

Scientific reports

Makos I, Orfanos I, Nayak A, Peschel J, Major B, Liontos I, Skantzakis E, Papadakis N, Kalpouzos C, Dumergue M, Kühn S, Varju K, Johnsson P, L'Huillier A, Tzallas P, Charalambidis D.
PMID: 32111920
Sci Rep. 2020 Feb 28;10(1):3759. doi: 10.1038/s41598-020-60331-9.

The quantum mechanical motion of electrons and nuclei in systems spatially confined to the molecular dimensions occurs on the sub-femtosecond to the femtosecond timescales respectively. Consequently, the study of ultrafast electronic and, in specific cases, nuclear dynamics requires the...

Cite
Makos I, Orfanos I, Nayak A, et al. Α 10-gigawatt attosecond source for non-linear XUV optics and XUV-pump-XUV-probe studies. Sci Rep. 2020;10(1):3759doi: 10.1038/s41598-020-60331-9.
Makos, I., Orfanos, I., Nayak, A., Peschel, J., Major, B., Liontos, I., Skantzakis, E., Papadakis, N., Kalpouzos, C., Dumergue, M., Kühn, S., Varju, K., Johnsson, P., L'Huillier, A., Tzallas, P., & Charalambidis, D. (2020). Α 10-gigawatt attosecond source for non-linear XUV optics and XUV-pump-XUV-probe studies. Scientific reports, 10(1), 3759. https://doi.org/10.1038/s41598-020-60331-9
Makos, I, et al. "Α 10-gigawatt attosecond source for non-linear XUV optics and XUV-pump-XUV-probe studies." Scientific reports vol. 10,1 (2020): 3759. doi: https://doi.org/10.1038/s41598-020-60331-9
Makos I, Orfanos I, Nayak A, Peschel J, Major B, Liontos I, Skantzakis E, Papadakis N, Kalpouzos C, Dumergue M, Kühn S, Varju K, Johnsson P, L'Huillier A, Tzallas P, Charalambidis D. Α 10-gigawatt attosecond source for non-linear XUV optics and XUV-pump-XUV-probe studies. Sci Rep. 2020 Feb 28;10(1):3759. doi: 10.1038/s41598-020-60331-9. PMID: 32111920; PMCID: PMC7048767.
Copy Download .nbib Format: NLM
Quality of Life, Depression, and Anxiety in Survivors of Critical Illness from a Greek ICU. A Prospective Observational Study.

Healthcare (Basel, Switzerland)

Vrettou CS, Mantziou V, Ilias I, Vassiliou AG, Orfanos SE, Kotanidou A, Dimopoulou I.
PMID: 34356227
Healthcare (Basel). 2021 Jul 05;9(7). doi: 10.3390/healthcare9070849.

The physical and psychological consequences of critical illness may affect intensive care unit survivors for up to five years, and hence, health-related quality of life has emerged as an important measure of outcome in this population. We aimed at...

Cite
Vrettou CS, Mantziou V, Ilias I, et al. Quality of Life, Depression, and Anxiety in Survivors of Critical Illness from a Greek ICU. A Prospective Observational Study. Healthcare (Basel). 2021;9(7)doi: 10.3390/healthcare9070849.
Vrettou, C. S., Mantziou, V., Ilias, I., Vassiliou, A. G., Orfanos, S. E., Kotanidou, A., & Dimopoulou, I. (2021). Quality of Life, Depression, and Anxiety in Survivors of Critical Illness from a Greek ICU. A Prospective Observational Study. Healthcare (Basel, Switzerland), 9(7), . https://doi.org/10.3390/healthcare9070849
Vrettou, Charikleia S, et al. "Quality of Life, Depression, and Anxiety in Survivors of Critical Illness from a Greek ICU. A Prospective Observational Study." Healthcare (Basel, Switzerland) vol. 9,7 (2021). doi: https://doi.org/10.3390/healthcare9070849
Vrettou CS, Mantziou V, Ilias I, Vassiliou AG, Orfanos SE, Kotanidou A, Dimopoulou I. Quality of Life, Depression, and Anxiety in Survivors of Critical Illness from a Greek ICU. A Prospective Observational Study. Healthcare (Basel). 2021 Jul 05;9(7). doi: 10.3390/healthcare9070849. PMID: 34356227; PMCID: PMC8303596.
Copy Download .nbib Format: NLM
Incidence and outcomes of COVID-19 in patients with pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension: data from the Hellenic pulmOnary hyPertension rEgistry (HOPE).

Hellenic journal of cardiology : HJC = Hellenike kardiologike epitheorese

Farmakis IT, Karyofyllis P, Frantzeskaki F, Demerouti E, Anthi A, Arvanitaki A, Pitsiou G, Naka KK, Bechlioulis A, Thomaidi A, Avgeropoulou A, Brili S, Mitrouska I, Manginas A, Orfanos SE, Tsangaris I, Giannakoulas G.
PMID: 34843997
Hellenic J Cardiol. 2021 Nov 26; doi: 10.1016/j.hjc.2021.10.002. Epub 2021 Nov 26.

No abstract available.

Cite
Farmakis IT, Karyofyllis P, Frantzeskaki F, et al. Incidence and outcomes of COVID-19 in patients with pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension: data from the Hellenic pulmOnary hyPertension rEgistry (HOPE). Hellenic J Cardiol. 2021;doi: 10.1016/j.hjc.2021.10.002.
Farmakis, I. T., Karyofyllis, P., Frantzeskaki, F., Demerouti, E., Anthi, A., Arvanitaki, A., Pitsiou, G., Naka, K. K., Bechlioulis, A., Thomaidi, A., Avgeropoulou, A., Brili, S., Mitrouska, I., Manginas, A., Orfanos, S. E., Tsangaris, I., & Giannakoulas, G. (2021). Incidence and outcomes of COVID-19 in patients with pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension: data from the Hellenic pulmOnary hyPertension rEgistry (HOPE). Hellenic journal of cardiology : HJC = Hellenike kardiologike epitheorese, . https://doi.org/10.1016/j.hjc.2021.10.002
Farmakis, Ioannis T, et al. "Incidence and outcomes of COVID-19 in patients with pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension: data from the Hellenic pulmOnary hyPertension rEgistry (HOPE)." Hellenic journal of cardiology : HJC = Hellenike kardiologike epitheorese vol. (2021). doi: https://doi.org/10.1016/j.hjc.2021.10.002
Farmakis IT, Karyofyllis P, Frantzeskaki F, Demerouti E, Anthi A, Arvanitaki A, Pitsiou G, Naka KK, Bechlioulis A, Thomaidi A, Avgeropoulou A, Brili S, Mitrouska I, Manginas A, Orfanos SE, Tsangaris I, Giannakoulas G. Incidence and outcomes of COVID-19 in patients with pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension: data from the Hellenic pulmOnary hyPertension rEgistry (HOPE). Hellenic J Cardiol. 2021 Nov 26; doi: 10.1016/j.hjc.2021.10.002. Epub 2021 Nov 26. PMID: 34843997; PMCID: PMC8619882.
Copy Download .nbib Format: NLM
Cost-effectiveness of low-dose colchicine after myocardial infarction in the Colchicine Cardiovascular Outcomes Trial (COLCOT).

European heart journal. Quality of care & clinical outcomes

Samuel M, Tardif JC, Khairy P, Roubille F, Waters DD, Grégoire JC, Pinto FJ, Maggioni AP, Diaz R, Berry C, Koenig W, Ostadal P, Lopez-Sendon J, Gamra H, Kiwan GS, Dubé MP, Provencher M, Orfanos A, Blondeau L, Kouz S, L'Allier PL, Ibrahim R, Bouabdallaoui N, Mitchell D, Guertin MC, Lelorier J.
PMID: 32407460
Eur Heart J Qual Care Clin Outcomes. 2021 Sep 16;7(5):486-495. doi: 10.1093/ehjqcco/qcaa045.

AIMS: In the randomized, placebo-controlled Colchicine Cardiovascular Outcomes Trial (COLCOT) of 4745 patients enrolled within 30 days after myocardial infarction (MI), low-dose colchicine (0.5 mg once daily) reduced the incidence of the primary composite endpoint of cardiovascular death, resuscitated...

Cite
Samuel M, Tardif JC, Khairy P, et al. Cost-effectiveness of low-dose colchicine after myocardial infarction in the Colchicine Cardiovascular Outcomes Trial (COLCOT). Eur Heart J Qual Care Clin Outcomes. 2021;7(5):486-495doi: 10.1093/ehjqcco/qcaa045.
Samuel, M., Tardif, J. C., Khairy, P., Roubille, F., Waters, D. D., Grégoire, J. C., Pinto, F. J., Maggioni, A. P., Diaz, R., Berry, C., Koenig, W., Ostadal, P., Lopez-Sendon, J., Gamra, H., Kiwan, G. S., Dubé, M. P., Provencher, M., Orfanos, A., Blondeau, L., Kouz, S., L'Allier, P. L., Ibrahim, R., Bouabdallaoui, N., Mitchell, D., Guertin, M. C., & Lelorier, J. (2021). Cost-effectiveness of low-dose colchicine after myocardial infarction in the Colchicine Cardiovascular Outcomes Trial (COLCOT). European heart journal. Quality of care & clinical outcomes, 7(5), 486-495. https://doi.org/10.1093/ehjqcco/qcaa045
Samuel, Michelle, et al. "Cost-effectiveness of low-dose colchicine after myocardial infarction in the Colchicine Cardiovascular Outcomes Trial (COLCOT)." European heart journal. Quality of care & clinical outcomes vol. 7,5 (2021): 486-495. doi: https://doi.org/10.1093/ehjqcco/qcaa045
Samuel M, Tardif JC, Khairy P, Roubille F, Waters DD, Grégoire JC, Pinto FJ, Maggioni AP, Diaz R, Berry C, Koenig W, Ostadal P, Lopez-Sendon J, Gamra H, Kiwan GS, Dubé MP, Provencher M, Orfanos A, Blondeau L, Kouz S, L'Allier PL, Ibrahim R, Bouabdallaoui N, Mitchell D, Guertin MC, Lelorier J. Cost-effectiveness of low-dose colchicine after myocardial infarction in the Colchicine Cardiovascular Outcomes Trial (COLCOT). Eur Heart J Qual Care Clin Outcomes. 2021 Sep 16;7(5):486-495. doi: 10.1093/ehjqcco/qcaa045. PMID: 32407460; PMCID: PMC8445085.
Copy Download .nbib Format: NLM
Coagulation Profiles of Pulmonary Arterial Hypertension Patients, Assessed by Non-Conventional Hemostatic Tests and Markers of Platelet Activation and Endothelial Dysfunction.

Diagnostics (Basel, Switzerland)

Vrigkou E, Tsantes AE, Kopterides P, Orfanos SE, Armaganidis A, Maratou E, Rapti E, Pappas A, Tsantes AG, Tsangaris I.
PMID: 32992591
Diagnostics (Basel). 2020 Sep 27;10(10). doi: 10.3390/diagnostics10100758.

Many pathophysiologic processes of pulmonary arterial hypertension (PAH), namely, excess vasoconstriction, vascular remodeling and in situ thrombosis, involve the coagulation cascade, and more specifically, platelets. The aim of this study was to globally assess coagulation processes in PAH, by...

Cite
Vrigkou E, Tsantes AE, Kopterides P, et al. Coagulation Profiles of Pulmonary Arterial Hypertension Patients, Assessed by Non-Conventional Hemostatic Tests and Markers of Platelet Activation and Endothelial Dysfunction. Diagnostics (Basel). 2020;10(10)doi: 10.3390/diagnostics10100758.
Vrigkou, E., Tsantes, A. E., Kopterides, P., Orfanos, S. E., Armaganidis, A., Maratou, E., Rapti, E., Pappas, A., Tsantes, A. G., & Tsangaris, I. (2020). Coagulation Profiles of Pulmonary Arterial Hypertension Patients, Assessed by Non-Conventional Hemostatic Tests and Markers of Platelet Activation and Endothelial Dysfunction. Diagnostics (Basel, Switzerland), 10(10), . https://doi.org/10.3390/diagnostics10100758
Vrigkou, Eleni, et al. "Coagulation Profiles of Pulmonary Arterial Hypertension Patients, Assessed by Non-Conventional Hemostatic Tests and Markers of Platelet Activation and Endothelial Dysfunction." Diagnostics (Basel, Switzerland) vol. 10,10 (2020). doi: https://doi.org/10.3390/diagnostics10100758
Vrigkou E, Tsantes AE, Kopterides P, Orfanos SE, Armaganidis A, Maratou E, Rapti E, Pappas A, Tsantes AG, Tsangaris I. Coagulation Profiles of Pulmonary Arterial Hypertension Patients, Assessed by Non-Conventional Hemostatic Tests and Markers of Platelet Activation and Endothelial Dysfunction. Diagnostics (Basel). 2020 Sep 27;10(10). doi: 10.3390/diagnostics10100758. PMID: 32992591; PMCID: PMC7601126.
Copy Download .nbib Format: NLM
Orbitofrontal control of conduct problems? Evidence from healthy adolescents processing negative facial affect.

European child & adolescent psychiatry

Böttinger BW, Baumeister S, Millenet S, Barker GJ, Bokde ALW, Büchel C, Quinlan EB, Desrivières S, Flor H, Grigis A, Garavan H, Gowland P, Heinz A, Ittermann B, Martinot JL, Martinot MP, Artiges E, Orfanos DP, Paus T, Poustka L, Fröhner JH, Smolka MN, Walter H, Whelan R, Schumann G, Banaschewski T, Brandeis D, Nees F.
PMID: 33861383
Eur Child Adolesc Psychiatry. 2021 Apr 16; doi: 10.1007/s00787-021-01770-1. Epub 2021 Apr 16.

Conduct problems (CP) in patients with disruptive behavior disorders have been linked to impaired prefrontal processing of negative facial affect compared to controls. However, it is unknown whether associations with prefrontal activity during affective face processing hold along the...

Cite
Böttinger BW, Baumeister S, Millenet S, et al. Orbitofrontal control of conduct problems? Evidence from healthy adolescents processing negative facial affect. Eur Child Adolesc Psychiatry. 2021;doi: 10.1007/s00787-021-01770-1.
Böttinger, B. W., Baumeister, S., Millenet, S., Barker, G. J., Bokde, A. L. W., Büchel, C., Quinlan, E. B., Desrivières, S., Flor, H., Grigis, A., Garavan, H., Gowland, P., Heinz, A., Ittermann, B., Martinot, J. L., Martinot, M. P., Artiges, E., Orfanos, D. P., Paus, T., Poustka, L., Fröhner, J. H., Smolka, M. N., Walter, H., Whelan, R., Schumann, G., Banaschewski, T., Brandeis, D., Nees, F. (2021). Orbitofrontal control of conduct problems? Evidence from healthy adolescents processing negative facial affect. European child & adolescent psychiatry, . https://doi.org/10.1007/s00787-021-01770-1
Böttinger, Boris William, et al. "Orbitofrontal control of conduct problems? Evidence from healthy adolescents processing negative facial affect." European child & adolescent psychiatry vol. (2021). doi: https://doi.org/10.1007/s00787-021-01770-1
Böttinger BW, Baumeister S, Millenet S, Barker GJ, Bokde ALW, Büchel C, Quinlan EB, Desrivières S, Flor H, Grigis A, Garavan H, Gowland P, Heinz A, Ittermann B, Martinot JL, Martinot MP, Artiges E, Orfanos DP, Paus T, Poustka L, Fröhner JH, Smolka MN, Walter H, Whelan R, Schumann G, Banaschewski T, Brandeis D, Nees F. Orbitofrontal control of conduct problems? Evidence from healthy adolescents processing negative facial affect. Eur Child Adolesc Psychiatry. 2021 Apr 16; doi: 10.1007/s00787-021-01770-1. Epub 2021 Apr 16. PMID: 33861383.
Copy Download .nbib Format: NLM
Orotracheal treprostinil administration attenuates bleomycin-induced lung injury, vascular remodeling, and fibrosis in mice.

Pulmonary circulation

Nikitopoulou I, Manitsopoulos N, Kotanidou A, Tian X, Petrovic A, Magkou C, Ninou I, Aidinis V, Schermuly RT, Kosanovic D, Orfanos SE.
PMID: 31819797
Pulm Circ. 2019 Nov 15;9(4):2045894019881954. doi: 10.1177/2045894019881954. eCollection 2019.

Pulmonary fibrosis is a progressive disease characterized by disruption of lung architecture and deregulation of the pulmonary function. Prostacyclin, a metabolite of arachidonic acid, is a potential disease mediator since it exerts anti-inflammatory and anti-fibrotic actions. We investigated the...

Cite
Nikitopoulou I, Manitsopoulos N, Kotanidou A, et al. Orotracheal treprostinil administration attenuates bleomycin-induced lung injury, vascular remodeling, and fibrosis in mice. Pulm Circ. 2019;9(4):2045894019881954doi: 10.1177/2045894019881954.
Nikitopoulou, I., Manitsopoulos, N., Kotanidou, A., Tian, X., Petrovic, A., Magkou, C., Ninou, I., Aidinis, V., Schermuly, R. T., Kosanovic, D., & Orfanos, S. E. (2019). Orotracheal treprostinil administration attenuates bleomycin-induced lung injury, vascular remodeling, and fibrosis in mice. Pulmonary circulation, 9(4), 2045894019881954. https://doi.org/10.1177/2045894019881954
Nikitopoulou, Ioanna, et al. "Orotracheal treprostinil administration attenuates bleomycin-induced lung injury, vascular remodeling, and fibrosis in mice." Pulmonary circulation vol. 9,4 (2019): 2045894019881954. doi: https://doi.org/10.1177/2045894019881954
Nikitopoulou I, Manitsopoulos N, Kotanidou A, Tian X, Petrovic A, Magkou C, Ninou I, Aidinis V, Schermuly RT, Kosanovic D, Orfanos SE. Orotracheal treprostinil administration attenuates bleomycin-induced lung injury, vascular remodeling, and fibrosis in mice. Pulm Circ. 2019 Nov 15;9(4):2045894019881954. doi: 10.1177/2045894019881954. eCollection 2019. PMID: 31819797; PMCID: PMC6883672.
Copy Download .nbib Format: NLM
Effect of Triiodothyronine Administration on the Kidney During Haemorrhagic Shock and Resuscitation.

Turkish journal of anaesthesiology and reanimation

Karmaniolou I, Lamprou K, Staikou C, Giamarellos-Bourboulis E, Theodoraki K, Papalois A, Mylonas A, Orfanos N, Smyrniotis V, Arkadopoulos N.
PMID: 33103146
Turk J Anaesthesiol Reanim. 2020 Oct;48(5):406-413. doi: 10.5152/TJAR.2019.81542. Epub 2020 Feb 05.

OBJECTIVE: Apoptosis, measured via caspase activity, can be used to assess renal tissue damage in haemorrhagic shock. We investigated whether Triiodothyronine could attenuate apoptosis and protect against haemorrhagic shock-induced renal injury.METHODS: Haemorrhagic shock was induced in swine until the...

Cite
Karmaniolou I, Lamprou K, Staikou C, et al. Effect of Triiodothyronine Administration on the Kidney During Haemorrhagic Shock and Resuscitation. Turk J Anaesthesiol Reanim. 2020;48(5):406-413doi: 10.5152/TJAR.2019.81542.
Karmaniolou, I., Lamprou, K., Staikou, C., Giamarellos-Bourboulis, E., Theodoraki, K., Papalois, A., Mylonas, A., Orfanos, N., Smyrniotis, V., & Arkadopoulos, N. (2020). Effect of Triiodothyronine Administration on the Kidney During Haemorrhagic Shock and Resuscitation. Turkish journal of anaesthesiology and reanimation, 48(5), 406-413. https://doi.org/10.5152/TJAR.2019.81542
Karmaniolou, Iosifina, et al. "Effect of Triiodothyronine Administration on the Kidney During Haemorrhagic Shock and Resuscitation." Turkish journal of anaesthesiology and reanimation vol. 48,5 (2020): 406-413. doi: https://doi.org/10.5152/TJAR.2019.81542
Karmaniolou I, Lamprou K, Staikou C, Giamarellos-Bourboulis E, Theodoraki K, Papalois A, Mylonas A, Orfanos N, Smyrniotis V, Arkadopoulos N. Effect of Triiodothyronine Administration on the Kidney During Haemorrhagic Shock and Resuscitation. Turk J Anaesthesiol Reanim. 2020 Oct;48(5):406-413. doi: 10.5152/TJAR.2019.81542. Epub 2020 Feb 05. PMID: 33103146; PMCID: PMC7556640.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 82 entries